Jump to content

Welcome to Tezi Mandee - Community Of Pakistani Investors & Traders
Register now to gain access to all of our features. Once registered and logged in, you will be able to create topics, post replies to existing threads, give reputation to your fellow members, get your own private messenger, post status updates, manage your profile and so much more. If you already have an account, login here - otherwise create an account for free today!

Welcome to Tezi Mandee - Community Of Pakistani Investors & Traders

Welcome to Tezi Mandee - Community Of Pakistani Investors & Traders, like most online communities you must register to view or post in our community, but don't worry this is a simple free process that requires minimal information for you to sign up. Be a part of Tezi Mandee - Community Of Pakistani Investors & Traders by signing in or creating an account.
  • Start new topics and reply to others
  • Get latest news on Karachi Stock Market
  • Subscribe to topics and forums to get automatic updates
  • Registered member get added in mailing list for mailing updates
  • Get your own profile and make new friends
  • Customize your experience here
  • Be the first to know the KSE latest announcements shared by our members
  • Registered members get access to Protected Forums and topics
  • Registration is free Create Account
  • If you are already a member just Sign in
To Create Account ( Click Here )
To Sign In ( Click Here )
 

FEROZ -- Ferozsons Laboratories Ltd.

- - - - - FEROZ Ferozsons Laboratories Ferozsons

317 replies to this topic

#1
AbDuLmAtEeNkHaN

    CAPTAIN

  • TEAM
  • 12,806 posts
  • Joined 10-February 06
  • Skin: Main Blue
  • Offline
    • Gender:Male
    • Country: Country Flag

    Current mood: Busy
    Reputation: 143
    01 September 2006

    BOOK CLOSURE TO 30/09/2006

    DIVIDEND = 40%(F)

    FINANCIAL RESULT FOR THE YEAR ENDED 3O/O6/2OO6

    BONUS ISSUE = 20%

    BOOK CLOSURE FROM 21/09/2006

    EPS = 17.51

    PROFIT/LOSS AFTER TAXATION RS. IN MILLION 175.869

    PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 218.137

    ANNUAL GENERAL MEETING WILL BE HELD ON 30/09/2OO6



    28 April 2006

    FINANCIAL RESULT FOR THE QUARTER ENDED 31/O3/2OO6

    PROFIT BEFORE TAXATION RS. IN MILLION 183.579

    PROFIT AFTER TAXATION RS. IN MILLION 137.879



    24 October 2005

    PROFIT AFTER TAXATION RS. IN MILLION 42.645

    FINANCIAL RESULT FOR THE QUARTER ENDED 3O/O9/2OO5

    PROFIT BEFORE TAXATION RS. IN MILLION 65.645



    30 August 2005

    BONUS ISSUE: 30%

    BOOK CLOSURE FROM 25/09/2OO5 TO 04/10/2OO5

    PROFIT AFTER TAXATION RS. IN MILLION 153.664

    PROFIT BEFORE TAXATION RS. IN MILLION 217.272

    ANNUAL GENERAL MEETING WILL BE HELD ON 29/09/2OO5

    FINAL DIVIDEND FOR THE YEAR ENDED 3O/O6/2OO5 55%



    28 April 2005

    PROFIT AFTER TAXATION RS. IN MILLION 96.811

    PROFIT BEFORE TAXATION RS. IN MILLION 140.811

    FINANCIAL RESULT FOR THE QUARTER ENDED 31/O3/2OO5



    28 January 2005

    BOOK CLOSURE FROM 26/O2/2OO5 TO O5/O3/2OO5

    PROFIT AFTER TAXATION RS. IN MILLION 62.3O7

    PROFIT BEFORE TAXATION RS. IN MILLION 91.186

    INTERIM DIVIDEND FOR THE HALF YEAR ENDED 31/12/2OO4 25%(i)



    01 November 2004

    FINANCIAL RESULT FOR THE QUARTER ENDED 3O/O9/2OO4

    PROFIT BEFORE TAXATION RS. IN MILLION 47.567

    PROFIT AFTER TAXATION RS. IN MILLION 31.567



    20 September 2004

    FINAL DIVIDEND FOR THE YEAR ENDED 3O/O6/2OO4 4O%

    BOOK CLOSURE FROM 26/1O/2OO4 TO O4/11/2OO4

    PROFIT BEFORE TAXATION RS. IN MILLION 149.263

    ANNUAL GENERAL MEETING WILL BE HELD ON 29/1O/2OO4

    PROFIT AFTER TAXATION RS. IN MILLION 1OO.892

    BONUS ISSUE = 4O%



    ========================



    Change 0.92 %

    Current Rate Rs. 174.7

    Open Rate Rs. 173.1

    Volume 1,900

    Bid x Bid Volume 173.50 x 1,000

    Offer x Offer Volume 175.00 x 700

    Today's Range 174.75 - 174.70

    52 Week Range 258.00 - 169.00

    Shares Outstanding 10,046,700

    EPS (lfye*) Rs. 17.5

    Avg. Volume (1 yr) 2,392

    P/E (lfye*) 9.98

    Market Cap. (in Mill.) Rs. 1,755

    Dividend Yield (lfye*) 0 %

    Year 2006 BVPS Rs. 77.59






    ===============================





    Accumlate in dip sell on strenth ....

    Posted Image




    Click Here For: "Daily Reports From Different Brokerage Houses"
    Note: Please make your own due diligence before making any decision

    Regards,
    Abdul Mateen Khan


    #2
    fahimabid

      Regular Member

    • Junior
    • 1,113 posts
    • Joined 20-April 06
  • Skin: Main Blue
  • Offline

    Current mood: None chosen
    Reputation: 0
    19-10-2004 ko is ka high tha 260

    or 15 02-2006 ko 247.90 kiya

    and is ka low 07-01-2004 ko tha 119

    it means ke abhi kafi attractive price per hai

    buying in this script is recommended

    #3
    fahimabid

      Regular Member

    • Junior
    • 1,113 posts
    • Joined 20-April 06
  • Skin: Main Blue
  • Offline

    Current mood: None chosen
    Reputation: 0
    is ke book closing kab se kab tak hai

    #4
    AbDuLmAtEeNkHaN

      CAPTAIN

    • TEAM
    • 12,806 posts
    • Joined 10-February 06
  • Skin: Main Blue
  • Offline
    • Gender:Male
    • Country: Country Flag

    Current mood: Busy
    Reputation: 143
    Pharmaceuticals: FEROZSONS LABORATORIES LIMITED - Year Ended 30-06-2006
    BR
    SCANNER
    OVERVIEW (October 07 2006): The year ended on June 30, 2006 is the 50th year of the company's operations. The completion of five decades of successful business marks an important milestone in its history.

    It is therefore befitting to the occasion of company's expansion in the area of biotech pharmaceutical manufacturing through its subsidiary BF Biosciences Ltd which is being set up in joint venture with the Bago Group of Argentina and is expected to come online in 2007.

    During the year under review the company achieved net sales at Rs 752.22 million registering 14.7% growth. The company's net profit after taxation amounted to Rs 175.87 million which works out to Earnings Per Share at Rs 17.51 as against Rs 15.29 in the preceding year.

    The Board recommended cash dividend @40% as well as stock dividend 20%. Demand growth for the pharmaceutical industry continued to remain at 12% during the year. However, inflationary pressures on inputs particularly energy, construction materials, increased the cost of operations as well as investment in the country.

    Ferozsons Laboratories Ltd was incorporated as a private limited company on January 28, 1954 and was converted into a public limited company on September 8, 1960.

    The company is listed on the Karachi, Lahore and Islamabad Stock Exchanges. The company is primarily engaged in manufacture and sale of pharmaceutical products. Its registered office is in Rawalpindi whereas its corporate office is situated at 14th Floor, Saudi Pak Tower, Jinnah Avenue Islamabad. It is domiciled in Rawalpindi and its manufacturing facilities are located in Nowshera NWFP.

    On September 26, the market value of its share was recorded at Rs 172 per share carrying very high premium over the par value. During the last one year market value of its share remained very high as it ranged between Rs 169 and Rs 258 per share. At the current market value its market capitalisation has soared to Rs 1.73 billion from a modest paid-up capital of Rs 100.47 million.

    The company has signed an agreement with laboratories Bago'SA, Argentina to set up the first biotech pharmaceutical plant in Pakistan for the manufacture of medicines to treat Hepatitis and Cancer, at an approximate initial cost of Rs 416 million. Major letter of credits with suppliers have been established. Erection, construction, installation and commissioning of the biotech plant, civil electrical, mechanical works for the central production building were also in line.

    The plant is scheduled to come online in 2007. The company directors are hopeful that through this plant the company will be able to make the country self-sufficient in treatment of Hepatitis C and Cancer and will also be able to leverage Bago' Group's global presence to develop a significant export base in the years to come.

    This facility is being set up under its subsidiary company BF Biosciences Ltd, in this Company, Ferozsons Laboratories Ltd holds 80% share of the equity and the remaining 20% is held by Laboratories Bago SA, Argentina.

    The year ended on June 30, 2006 under review is also the company's 50th year of operations. During the year company posted net sales in the sum of Rs 752.22 million registering 14.7% growth as compared to Rs 655.76 million posted in the preceding year. However the growth rate of gross profit was a little less at 14.1%. The main reasons for lower growth rate of Gross Profit were increase in raw material consumed, devaluation of rupee against Euro and higher depreciation resulting from a change in the company's depreciation policy.

    The directors reported that the company changed its depreciation policy to the straight line method, and also undertook revaluation of its assets in order to keep its financial statements in line with international accounting standards.

    The company earned net profit after taxation at Rs 175.87 million as against Rs 153.57 million in the previous year.

    Posted Image




    Click Here For: "Daily Reports From Different Brokerage Houses"
    Note: Please make your own due diligence before making any decision

    Regards,
    Abdul Mateen Khan

    #5
    AbDuLmAtEeNkHaN

      CAPTAIN

    • TEAM
    • 12,806 posts
    • Joined 10-February 06
  • Skin: Main Blue
  • Offline
    • Gender:Male
    • Country: Country Flag

    Current mood: Busy
    Reputation: 143
    Ferozsons Laboratories Pakistan Ltd

    EPS = 8.61

    Posted Image




    Click Here For: "Daily Reports From Different Brokerage Houses"
    Note: Please make your own due diligence before making any decision

    Regards,
    Abdul Mateen Khan

    #6
    AbDuLmAtEeNkHaN

      CAPTAIN

    • TEAM
    • 12,806 posts
    • Joined 10-February 06
  • Skin: Main Blue
  • Offline
    • Gender:Male
    • Country: Country Flag

    Current mood: Busy
    Reputation: 143
    29-AUG-07 FEROZ Ferozsons (Lab) FINANCIAL RESULT FOR THE YEAR ENDED 30/06/2OO7
    29-AUG-07 FEROZ Ferozsons (Lab) DIVIDEND = 65%
    29-AUG-07 FEROZ Ferozsons (Lab) BONUS ISSUE = 20%

    29-AUG-07 FEROZ Ferozsons (Lab) PROFIT/LOSS BEFORE TAXATION RS. IN MILLION 258.513
    29-AUG-07 FEROZ Ferozsons (Lab) PROFIT/LOSS AFTER TAXATION RS. IN MILLION 200.254
    29-AUG-07 FEROZ Ferozsons (Lab) EPS = 16.61
    29-AUG-07 FEROZ Ferozsons (Lab) ANNUAL GENERAL MEETING WILL BE HELD ON 29/09/2OO7
    29-AUG-07 FEROZ Ferozsons (Lab) BOOK CLOSURE FROM 20/09/2007
    29-AUG-07 FEROZ Ferozsons (Lab) BOOK CLOSURE TO 29/09/2007

    Posted Image




    Click Here For: "Daily Reports From Different Brokerage Houses"
    Note: Please make your own due diligence before making any decision

    Regards,
    Abdul Mateen Khan






    Karachi Stock Exchange (KSE) Daily Reports


    Top Pakistani Sites        Haroof Top Sites    Promoted at Global Promote

    Indemnity, Disclaimer & Disclosure Notice:
    • By visiting TeziMandee.com you indicate your acceptance of our Forum Rules Disclaimer & Disclosure and indemnify TeziMandee.com, its associates and related parties of all claims howsoever resulting from the usage of the forum.
    Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. TeziMandee.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.
    Disclosure: The information in this forum is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.
    • All names or products mentioned are trademarks or registered trademarks of their respective owners.

    Copyright © 2006 - 2012, TeziMandee.com All Rights Reserved.
    eXTReMe Tracker